Company facts
- Headquarters
- Emeryville, California
- Most recent report
- 8-K, filed Sep 28, 2026
- Incorporated
- Delaware
- Filings on record
- 436 filings
- On EDGAR
- CIK 1650648
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 23
News 8 of 66
Prospectuses and Registrations 8 of 29
- S-3 Shelf registration statement May 7, 2026
- S-8 Registration statement for an employee plan Mar 18, 2026
- 424B5 Prospectus supplement for an offering Nov 6, 2025
- S-8 Registration statement for an employee plan May 8, 2025
- POS AM Post-effective amendment to a registration Feb 28, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
- 424B5 Prospectus supplement for an offering Jun 7, 2024
- S-8 Registration statement for an employee plan Feb 29, 2024
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 10, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2024
- DEFA14A Extra proxy material Apr 12, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2023
Ownership 8 of 265
- 4 Insider reported a trade Sep 22, 2026
- 4 Insider reported a trade Sep 16, 2026
- 144 Notice of a proposed sale of restricted stock Sep 14, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Aug 21, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 4 Insider reported a trade Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
Other 8 of 41
- EFFECT Notice that a registration became effective May 13, 2026
- CORRESP Reply to SEC staff May 11, 2026
- UPLOAD Comment letter from SEC staff May 8, 2026
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- EFFECT Notice that a registration became effective Mar 24, 2025
- POSASR Feb 28, 2025
- ARS Annual report sent to shareholders Apr 10, 2024
Everything here comes from 4D Molecular Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.